Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa, a science writer, holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

July 20, 2020July 20, 2020

Urine Marker Could Help in Screening for CF Lung Infections, Study Finds

cystic fibrosis, News

Measuring levels of a molecule called lipoarabinomannan, or LAM, in a person’s urine could be an easier way of screening for airway infections due to nontuberculous mycobacteria in people ... Read more

July 14, 2020July 14, 2020

Number of Adults With CF Likely to Grow by 28% Over Decade, UK Study Says

cystic fibrosis, News

The number of adults with cystic fibrosis (CF) living in the U.K. is expected to increase by at least 28% in 10 years, and 36% of these adults will ... Read more

July 13, 2020July 13, 2020

NIH Grant Supports Computer Modeling of Bacteria’s Behavior in Mucus

News

A five-year, $3.2 million grant from the National Institutes of Health (NIH) will fund a research project that aims to better understand the interactions between bacteria and mucus. Results ... Read more

July 10, 2020July 10, 2020

Renovion’s ARINA-1 Shows Promise in Clearing Mucus, Cell Study Finds

News

ARINA-1, a nebulized therapy being developed by Renovion for cystic fibrosis (CF) and other chronic inflammatory lung diseases, may be better than currently available options for clearing mucus in CF patients ... Read more

July 9, 2020July 10, 2020

Rage Biotech Opens With Goal of Treating CF and Similar Lung Diseases

News

Rage Biotech, a new company building on research done at leading Australian universities, aims to develop treatments to help people with chronic inflammatory lung diseases, including cystic fibrosis, severe asthma, ... Read more

July 1, 2020July 1, 2020

NHS, Vertex Strike Deal to Make Kaftrio Available in England

cystic fibrosis, News

NHS England and Vertex Pharmaceuticals have reached an agreement that will allow access to Vertex’s Kaftrio (ivacaftor/tezacaftor/elexacaftor), a triple combination therapy for cystic fibrosis (CF) to be used in ... Read more

June 29, 2020July 20, 2020

CHMP Gives Positive Opinion to Vertex’s Triple Combination Therapy Kaftrio

cystic fibrosis, News

The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with Kalydeco (ivacaftor) as a treatment for cystic fibrosis (CF) in ... Read more

June 26, 2020June 26, 2020

Drying Does Not Clear Nebulizers of NTM Bacteria, Study Finds

cystic fibrosis, News

Nontuberculous mycobacteria (NTM), a type of infectious bacteria, is able to survive being dried for a full day, a study found, suggesting that drying is not a sufficient way ... Read more

June 18, 2020June 18, 2020

Poll Results Highlight Lack of Awareness About Cystic Fibrosis in the UK

cystic fibrosis, News

Most people in the U.K. are unaware of the challenges faced by people living with cystic fibrosis (CF), according to results of a YouGov poll commissioned by the U.K. Cystic Fibrosis ... Read more

June 16, 2020June 16, 2020

3rd Annual CF FamilyCon, Free and Online, Starts Thursday

cystic fibrosis, News

The third annual CF FamilyCon, a free and online event that connects people with cystic fibrosis (CF) and their extended families and friends with one another — and to ... Read more